Unexpectedly, most SARS patients experience a robust upregulation of type-I interferon during the early phase of infection that occurs concurrently with an upregulation in the expression of IFN-stimulated chemokines (CXCL-10 and CCL-2). Here, CCL2 is linked to severe acute respiratory syndrome.